{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:42:03Z","timestamp":1785811323205,"version":"3.56.0"},"reference-count":120,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2024,5,3]]},"DOI":"10.1080\/13543784.2024.2343789","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T18:57:00Z","timestamp":1713034620000},"page":"485-495","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Sodium\/bile acid co-transporter inhibitors currently in preclinical or early clinical development for the treatment of primary biliary cholangitis"],"prefix":"10.1080","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0794-5789","authenticated-orcid":false,"given":"Abhishek","family":"Gairola","sequence":"first","affiliation":[{"name":"Liver Unit, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-9726","authenticated-orcid":false,"given":"Aaron","family":"Wetten","sequence":"additional","affiliation":[{"name":"Liver Unit, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK"},{"name":"Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Dyson","sequence":"additional","affiliation":[{"name":"Liver Unit, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK"},{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00154-3"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1383730"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.12.007"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-022-07581-x"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.07.038"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.029"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70183-5"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(03)00134-4"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509840"},{"key":"e_1_3_4_13_1","first-page":"1","article-title":"Adult liver transplantation: a UK clinical guideline-part 1: pre-operation","author":"Millson C","year":"2020","unstructured":"Millson C, Considine A, Cramp ME, et al. Adult liver transplantation: a UK clinical guideline-part 1: pre-operation. Gastroenterology [Internet]. 2020 [cited 2023 Dec 15];1\u201310. Available from: https:\/\/www","journal-title":"Gastroenterology [Internet]"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-023-07862-z"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1518"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714519"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.10.001"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.013"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15039"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000395"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90442-8"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01300759"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90335-V"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.08662.x"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21553"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90102-5"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-3-199508010-00001"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9322521"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00318-5"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218459"},{"key":"e_1_3_4_31_1","unstructured":"Mirum Pharmaceuticals Inc. A study to evaluate efficacy and safety of an investigational drug named volixibat in patients with itching caused by primary biliary cholangitis (VANTAGE) [Internet]. [cited 2023 Dec 15]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05050136#study-plan"},{"key":"e_1_3_4_32_1","unstructured":"Mirum Pharmaceuticals Inc. A study to evaluate efficacy and safety of an investigational drug named volixibat in patients with itching caused by primary sclerosing cholangitis (PSC) (VISTAS) [Internet]. [cited 2023 Dec 15]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04663308"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00093-0"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.10.024"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25214-0"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01594-y"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1305"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01256-3"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01649-0"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.10.032"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30319-7"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5946.693"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1974.01630050024005"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64551"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.042"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129866"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.13.3.201"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)31870-0"},{"key":"e_1_3_4_49_1","first-page":"77","article-title":"Itch in liver disease: facts and speculations","volume":"52","author":"Ghent CN","year":"1979","unstructured":"Ghent CN, Bloomer JR. Itch in liver disease: facts and speculations. Yale J Biol Med [Internet]. 1979 [cited 2023 Dec 15];52:77. Available from: \/pmc\/articles\/PMC2595714\/?report=abstract","journal-title":"Yale J Biol Med [Internet]"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0630065"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315259"},{"issue":"4","key":"e_1_3_4_52_1","first-page":"599","article-title":"Relief of pruritus by cholestyramine in chronic liver disease","volume":"1","author":"Oster ZH","year":"1965","unstructured":"Oster ZH, Rachmilewitz EA, Moran E, et al. Relief of pruritus by cholestyramine in chronic liver disease. Isr J Med Sci. 1965;1(4):599\u2013606.","journal-title":"Isr J Med Sci"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5325.216"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(66)80071-9"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6436.22"},{"issue":"12","key":"e_1_3_4_56_1","first-page":"773","article-title":"Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids","volume":"6","author":"Di Padova C","year":"1984","unstructured":"Di Padova C, Tritapepe R, Rovagnati P, et al. Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids. Methods Find Exp Clin Pharmacol. 1984;6(12):773\u2013776.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23821"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13449"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3182a9097c"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-014-3559-x"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90301-0"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-011-2058-8"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13281"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-016-9775-9"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.04.023"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2704"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)90090-2"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1981.tb08609.x"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(88)90085-1"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.4140\/TCP.n.2015.221"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.08.043"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6658.1241"},{"issue":"11","key":"e_1_3_4_73_1","first-page":"2028","article-title":"Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis","volume":"89","author":"Spivey JR","year":"1994","unstructured":"Spivey JR, Jorgensen RA, Gores GJ, et al. Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol. 1994;89(11):2028\u20132032.","journal-title":"Am J Gastroenterol"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90857-U"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(92)90040-V"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6662.1501"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70225-3"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i7.1125"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.27714"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3188"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1159\/000078632"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1113\/JP273961"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.03.019"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25748"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14069"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26531-0"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep30847"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.24"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12997"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep46705"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i11.1239"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.035"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.08.006"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90027-X"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14579"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.4.924"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep36286"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2015.05.044"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199401000-00005"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574887114666190328130720"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.287"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c120027"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-S355"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-14541-4_4"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-234185"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27973"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2022.100261"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10107-0"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf4823"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.576"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000595"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-017-0429-7"},{"key":"e_1_3_4_113_1","unstructured":"Mirum pharmaceuticals international B.V. Annex i summary of product characteristics [Internet]. 2022 [cited 2023 Dec 15]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/livmarli-epar-product-information_en.pdf."},{"key":"e_1_3_4_114_1","unstructured":"Albireo AB Annex i summary of product characteristics [Internet]. 2021 [cited 2023 Dec 15]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bylvay-epar-product-information_en.pdf"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13457"},{"issue":"1","key":"e_1_3_4_116_1","article-title":"A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis","volume":"19","author":"Palmer M","year":"2018","unstructured":"Palmer M, Jennings L, Silberg DG, et al. A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis. BMC Pharmacol Toxicol [Internet]. 2018 [cited 2023 Dec 15];19(1). Available from: \/pmc\/articles\/PMC5857122\/","journal-title":"BMC Pharmacol Toxicol [Internet]"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0736-0"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100573"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000376"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.024"},{"key":"e_1_3_4_121_1","unstructured":"GlaxoSmithKline. Global linerixibat itch study of efficacy and safety in primary biliary cholangitis (PBC) (GLISTEN) [Internet]. [cited 2023 Dec 15]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04950127#study-plan"},{"key":"e_1_3_4_122_1","unstructured":"NICE. Odevixibat for treating progressive familial intrahepatic cholestasis [Internet]. 2022 [cited 2023 Dec 15]. Available from: https:\/\/www.nice.org.uk\/guidance\/HST17"},{"key":"e_1_3_4_123_1","unstructured":"European Medicines Agency. Livmarli [Internet]. 2023 [cited 2023 Dec 15]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/livmarli"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2024.2343789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T08:44:36Z","timestamp":1718700276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2024.2343789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":120,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,3]]}},"alternative-id":["10.1080\/13543784.2024.2343789"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2024.2343789","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}